Overview

A Phase 1, 3 Day Study of Safety and Tolerability of NVN1000 Topical Gel in Healthy Volunteers

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
A Phase I, Single-Center, Open-Label, Randomized, Parallel Group, 3 Day Study Evaluating the Safety and Cutaneous Tolerability of NVN1000 Topical Gel in Healthy Volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Novan, Inc.